By this mechanism, A2AR stimulation could counteract and reduce the cognitive dysfunction caused by the elevated brain levels of the endogenous NMDAR antagonist KYNA in pathological situations (e.g., schizophrenia). Here, ADORA2A is linked to schizophrenia.